BIMEKIZUMAB-BKZX for Dermatitis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 5 adverse event reports in the FDA FAERS database where BIMEKIZUMAB-BKZX was used for Dermatitis.
Most Reported Side Effects for BIMEKIZUMAB-BKZX
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product dose omission issue | 694 | 13.0% | 0 | 24 |
| Psoriasis | 621 | 11.6% | 0 | 9 |
| Drug ineffective | 402 | 7.5% | 0 | 11 |
| Product availability issue | 364 | 6.8% | 0 | 17 |
| Off label use | 335 | 6.3% | 3 | 39 |
| Psoriatic arthropathy | 301 | 5.6% | 0 | 15 |
| Injection site pain | 263 | 4.9% | 0 | 8 |
| Therapy interrupted | 252 | 4.7% | 0 | 15 |
| Hidradenitis | 233 | 4.4% | 0 | 14 |
| Inappropriate schedule of product administration | 214 | 4.0% | 0 | 11 |
| Incorrect dose administered | 209 | 3.9% | 0 | 5 |
| Oral candidiasis | 178 | 3.3% | 0 | 9 |
| Pain | 159 | 3.0% | 1 | 5 |
| Fatigue | 148 | 2.8% | 0 | 6 |
| Headache | 146 | 2.7% | 0 | 7 |
Other Indications for BIMEKIZUMAB-BKZX
Psoriasis (3,059)
Psoriatic arthropathy (1,033)
Product used for unknown indication (716)
Hidradenitis (598)
Ankylosing spondylitis (199)
Off label use (199)
Axial spondyloarthritis (55)
Rheumatoid arthritis (39)
Dermatitis atopic (31)
Illness (21)
Other Drugs Used for Dermatitis
DUPILUMAB (9,959)
CRISABOROLE (407)
APREMILAST (122)
TRALOKINUMAB-LDRM (90)
KETOCONAZOLE (66)
CYCLOSPORINE (62)
DOXYCYCLINE (57)
PIMECROLIMUS (55)
CLOBETASOL (50)
RUXOLITINIB (50)